>
>
Comprehensive Metabolic Panel Testing Market - By Test Type (Glucose, Calcium, Electrolytes, Kidney Function Tests, Liver Function Tests, Proteins), By Disease Indication (Kidney Diseases
Download Free PDF

Comprehensive Metabolic Panel Testing Market
Get a free sample of this reportGet a free sample of this report Comprehensive Metabolic Panel Testing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 14
Tables & Figures: 401
Countries covered: 21
Pages: 256
Download Free PDF
Comprehensive Metabolic Panel Testing Market Size
Comprehensive Metabolic Panel Testing Market size was valued at USD 12.8 billion in 2022 and is estimated to account for USD 29.5 billion by 2032. Comprehensive metabolic panel (CMP) testing is a blood test that provides essential information about the body's chemical balance and metabolism.
The industry is being driven by the growing elderly population base as they are more susceptible to diabetes and cardiovascular ailments. For instance, the WHO estimates that by 2030, there will be 1.4 billion people worldwide that are over 60 years. Thus, surge in geriatric population base coupled with rising chronic diseases is estimated to augment market progress.
Additionally, one of the diseases with the largest global growth rates is diabetes, which increases the patient population for point-of-care (PoC) comprehensive metabolic panel testing. Over the projection period, it is predicted that the prevalence of cardiovascular, diabetes, and other target illnesses would increase, driving up demand for comprehensive metabolic panel testing. Nearly 17.9 million people die each year as a result of cardiovascular illnesses (CVDs).
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the blood testing market, which reached USD 74.9 billion in 2022, primarily due to increased demand for diagnostic procedures. Due to the rise of COVID-19, numerous blood tests were performed. Healthcare professionals ordered CMP tests to examine the complete blood count, d-dimer testing, and point of care testing products in COVID positive patients, and this surge in testing fuelled the market for metabolic panels as a whole. These factors collectively led to increased adoption of comprehensive metabolic panel testing and thereby augmented market expansion.
Comprehensive Metabolic Panel Testing Market Trends
Technological advancements have led to more precise and efficient analytical techniques. These techniques can provide more detailed information from CMP tests, aiding in the diagnosis and monitoring of various health conditions.
Comprehensive Metabolic Panel Testing Market Analysis
The market by test type is categorized into glucose, calcium, electrolytes, kidney function tests, liver function tests, and proteins. The glucose segment garnered USD 3.1 billion revenue size in the year 2022.
The comprehensive metabolic panel testing market by disease indication is categorized into kidney diseases, liver diseases, diabetes, and other indications. The kidney diseases segment garnered USD 4.6 billion revenue size in the year 2022.
The comprehensive metabolic panel testing market by end-use is categorized into point of care centers, hospitals, diagnostic laboratories, and other end-users. The diagnostic laboratories segment garnered USD 5.7 billion revenue size in the year 2022.
U.S. comprehensive metabolic panel testing market accounted for USD 4.9 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
Comprehensive Metabolic Panel Testing Market Share
The comprehensive metabolic panel testing industry is consolidated, with major players such as Quest Diagnostics, Sonic Healthcare, and others dominating the market. These companies are focused on continuous test type innovation to secure a significant market share. For instance, in December 2021, Sonic Healthcare acquired ProPath. Under the supervision of a group of top-tier medical experts and researchers, ProPath frequently diagnoses patients from 45 states in the U.S. and numerous other countries. Thus, such acquisitions enable the company to expand and build a larger customer base.
Some of the eminent market participants operating in the comprehensive metabolic panel testing industry include:
Comprehensive Metabolic Panel Testing Industry News:
Comprehensive metabolic panel testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Test Type, 2018-2032 (USD Million)
By Disease Indication, 2018-2032 (USD Million)
By End-use, 2018-2032 (USD Million)
The above information is provided for the following regions and countries: